Brandsmiths has chosen Pancreatic Cancer UK as our company charity until 2022. We are pleased to be able to raise funds for a charity that has impacted the Brandsmiths family directly, helping to support people affected by Pancreatic cancer and to research breakthroughs to prevent others being taken too soon.

We can make a difference to people living with Pancreatic cancer because:

. Pancreatic cancer receives around only 1% of National Cancer Research Institute partners. research spend (2013 figures). £3,539.53 per death per year is spent on breast cancer research compared to £618.54 per death per year on pancreatic cancer;

. One person dies from the disease every hour across the UK. Across the UK around 8,800 people are diagnosed with and 8,700 people die from pancreatic cancer each year. It is responsible for 5.2% of all cancer deaths in the UK and predicted to overtake breast cancer as the 4th most common cancer killer by 2030;

. Whilst survival rates for most forms of cancer have been rising, the five-year survival rates for pancreatic cancer have remained largely unchanged and shockingly low for the past 40 years, at less than 5%: this is the worst survival outcome for any of the 21 most common cancers;

. Late diagnosis is a major problem. Around 80% of pancreatic cancer patients are diagnosed at a point when the disease is metastatic . i.e. spread to other organs and when potentially curative surgery is not an option. For this cohort of metastatic patients, the average survival is just 2-6 months.